AstraZeneca India launches Eculizumab to treat aHUS and PNH
AstraZeneca India, a leading global biopharmaceutical company has launched Eculizumab concentrate solution for infusion (300 mg,10…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.